Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.56% slipped 2.39% to $155.93 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.04% falling 1.90% to 4,567.00 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.38% falling 1.86% to 34,483.72. Johnson & Johnson closed $23.99 below its 52-week high ($179.92), which the company achieved on August 20th.
The stock underperformed when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +0.48% fell 1.28% to $385.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.50% rose 0.03% to $74.91, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.63% rose 2.54% to $53.73. Trading volume (14.4 M) eclipsed its 50-day average volume of 6.7 M.